[Minor role of the de novo pathway in the biosynthesis of RNA during fetal and neoplastic liver development in rats].
D000348:Aflatoxins; D000367:Age Factors; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000378:metabolism*; D000242:Cyclic AMP / Q000494:pharmacology; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008099:Liver / Q000196:embryology / Q000378:metabolism*; D008113:Liver Neoplasms / Q000139:chemically induced / Q000378:metabolism*; D008297:Male; D008431:Maternal-Fetal Exchange; D008722:Methods; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000378:metabolism; D009963:Orotic Acid / Q000378:metabolism* / Q000494:pharmacology; D010758:Phosphorus / Q000378:metabolism; D010759:Phosphorus Isotopes; D011247:Pregnancy; D012313:RNA / Q000096:biosynthesis*; D051381:Rats; D013936:Thymidine / Q000378:metabolism
D000348:Aflatoxins; D010759:Phosphorus Isotopes; D010758:Phosphorus; D009963:Orotic Acid; D012313:RNA; D005934:Glucagon; D000242:Cyclic AMP; D013936:Thymidine
Rôle mineur de la voie de novo dans la biosynthèse du RNA au cours du développement foetal et néoplasique du foie chez le rat.